Aprotinin US Special Access Protocol
Public ClinicalTrials.gov record NCT00611845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Aprotinin US Special Access Protocol: An Open Label, Non-Comparative Treatment Protocol for the Use of Aprotinin in Patients Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass Who Are at Increased Risk of Blood Loss and Transfusion
Study identification
- NCT ID
- NCT00611845
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- Bayer
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Aprotinin (Trasylol, BAYA0128) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 22, 2014
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Decatur | Alabama | 35601 | — |
| Not listed | Glendale | California | 91206 | — |
| Not listed | Pismo Beach | California | 93449 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Ventura | California | 93003 | — |
| Not listed | Fort Wayne | Indiana | 46804 | — |
| Not listed | Edgewood | Kentucky | 41017 | — |
| Not listed | New Brunswick | New Jersey | 08903 | — |
| Not listed | Asheville | North Carolina | 28805 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Portland | Oregon | 97225 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Knoxville | Tennessee | 37917 | — |
| Not listed | Lynchburg | Virginia | 24501 | — |
| Not listed | Milwaukee | Wisconsin | 53215 | — |
| Not listed | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00611845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00611845 live on ClinicalTrials.gov.